Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
NovaBridge Biosciences (NBP) had Operating Cash Flow per Share of $-0.22 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-46.27M |
|
-- |
|
-- |
|
$94.27M |
|
$-94.27M |
|
$5.93M |
|
$-88.34M |
|
$-88.34M |
|
$-88.34M |
|
$-88.34M |
|
$-88.34M |
|
$-88.34M |
|
$-94.27M |
|
$-93.41M |
|
95.77M |
|
95.77M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$217.52M |
|
$0.14M |
|
$43.00M |
|
$260.52M |
|
$26.89M |
|
-- |
|
$2.69M |
|
$29.58M |
|
$230.94M |
|
$230.94M |
|
$230.94M |
|
115.38M |
|
| Cash Flow Statement Financials | |
$-20.60M |
|
$104.97M |
|
$57.73M |
|
$68.26M |
|
$210.63M |
|
$142.37M |
|
$5.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.25% |
|
-38.25% |
|
-33.91% |
|
-38.25% |
|
$2.00 |
|
$-0.21 |
|
|
Operating Cash Flow per Share |
$-0.22 |